Dark Forest Capital Management LP Arcutis Biotherapeutics, Inc. Transaction History
Dark Forest Capital Management LP
- $718 Million
- Q3 2024
A detailed history of Dark Forest Capital Management LP transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 16,817 shares of ARQT stock, worth $166,992. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,817
Previous 27,612
39.1%
Holding current value
$166,992
Previous $256,000
39.06%
% of portfolio
0.02%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding ARQT
# of Institutions
196Shares Held
129MCall Options Held
746KPut Options Held
82K-
Jennison Associates LLC11.7MShares$116 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$109 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$106 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$87.2 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$85.6 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $598M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...